Nectome
PrivateLast Round
Seed
Mar 1, 2018
Total Funding Raised
$2.88M
Company Overview
Nectome is a biotechnology research company focused on developing aldehyde-stabilized cryopreservation technology for long-term brain and memory preservation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging
Business Model
B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nectome Comparables
Compare Nectome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eon Systems | 65% | |
| Cryoport | 32% |
Nectome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 1, 2018 | ||||
| Grant | Sep 21, 2016 |
Nectome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| Y Combinator | Seed |
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 134% MoM, reaching 16.2K.
- Mar 1, 2018
$1M round led by Y Combinator
Nectome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nectome's valuation, stock price, and market status.
Is Nectome a public or private company?
Nectome is a private company.
What is the current stock price of Nectome?
Nectome is a private company with no public stock price. No recent secondary market data is available.
How much is Nectome worth (valuation)?
Valuation information for Nectome is not publicly available.
Can I buy Nectome stock?
Nectome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nectome's last funding round?
Nectome's most recent funding round was Seed on March 19, 2018.
Who are the main investors in Nectome?
Key investors in Nectome include Y Combinator.
Will Nectome IPO soon?
No public IPO plans have been announced for Nectome.
How can I track Nectome secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nectome's secondary market activity and sign up for updates.